Indomethacin and retinoic acid modify mouse intestinal inflammation and fibrosis: A role for SPARC

Digestive Diseases and Sciences

Volumn 53, Issue 6, 2008, Pages 1553-1563

  Klopcic, Borut ^a   Appelbee, Amber ^b   Raye, Warren ^b   Lloyd, Frances ^b   Jooste, James C I ^b   Forrest, Cynthia Heather ^b   Lawrance, Ian Craig ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

Author keywords

Fibrosis; Indomethacin; Mouse; Retinoic acid; SPARC; TNBS

Indexed keywords

CD1 ANTIGEN; INDOMETACIN; OSTEONECTIN; RETINOIC ACID; TRINITROBENZENESULFONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENTERITIS; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINAL FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION;

ANIMALS; CROHN DISEASE; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; IMMUNOENZYME TECHNIQUES; INDOMETHACIN; MICE; OSTEONECTIN; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STATISTICS, NONPARAMETRIC; TRETINOIN; TRINITROBENZENESULFONIC ACID;

EID: 43049124446     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-0068-y     Document Type: Article

References (25)

1. Farmer RG, Whelan G, Fazio VW (1985) Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 88(6):1818-1825
2. Morris GP, Beck PL, Herridge MS, Depew WT et al. (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96(3):795-803
3. Neurath MF, Fuss I, Kelsall BL et al. (1995) Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182(5):1281-1290
4. Lawrance IC, Wu F, Leite AZ et al. (2003) A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B. Gastroenterology 125(6):1750-1761
5. Shankavaram UT, DeWitt DL, Funk SE, Sage EH, Wahl LM (1997) Regulation of human monocyte matrix metalloproteinases by SPARC. J Cell Physiol 173(3):327-334
6. Moreland RB, Traish, A., McMillin, M.A., Smith, B et al. (1995) PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. J Urol 153(3 Pt 1):826-834
7. Johnson PR, Armour CL, Carey D, Black JL (1995) Heparin and PGE2 inhibit DNA synthesis in human airway smooth muscle cells in culture. Am J Physiol 269(4 Pt 1):L514-L519
8. Anthony A, Dhillon AP, Sim R et al. (1994) Ulceration, fibrosis and diaphragm-like lesions in the caecum of rats treated with indomethacin. Aliment Pharmacol Ther 8(4):417-424
9. Elson CO, Sartor RB, Tennyson GS, Riddell RH (1995) Experimental models of inflammatory bowel disease. Gastroenterology 109(4):1344-1367
10. Davis BH, Rapp UR, Davidson NO (1991) Retinoic acid and transforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation. Biochem J 278(Pt 1):43-47
11. Torry DJ et al. (1996) Modulation of the anchorage-independent phenotype of human lung fibroblasts obtained from fibrotic tissue following culture with retinoid and corticosteroid. Exp Lung Res 22(2):231-244
12. Meisler NT, Parrelli J, Gendimenico GJ et al. (1997) All-trans-retinoic acid inhibition of Pro alpha1(I) collagen gene expression in fetal rat skin fibroblasts: identification of a retinoic acis response element in the Pro alpha1(I) collagen gene. J Invest Dermatol 108(4):476-481
13. Wilborn J, Crofford, LJ, Burdick, MD et al. (1995) Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest 95(4):1861-1868
14. Everitt EA, Sage EH (1992) Expression of SPARC is correlated with altered morphologies in transfected F9 embryonal carcinoma cells. Exp Cell Res 199(1):134-146
15. Bradshaw AD, Sage EH (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107(9):1049-1054
16. Reed MJ, Puolakkainen P, Lane TF, Dickerson D, Bornstein P, Sage EH (1993) Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. J Histochem Cytochem 41(10):1467-1477
17. Puolakkainen P, Reed M, Vento P, Sage EH, Kiviluoto T, Kivilaakso E (1999) Expression of SPARC (secreted protein, acidic and rich in cysteine) in healing intestinal anastomoses and short bowel syndrome in rats. Dig Dis Sci 44(8):1554-1564
18. Lawrance IC, Fiocchi C, Chakravarti S (2001) Gene expression profiling identify distinctive disease signatures for ulcerative colitis and Crohn's disease. Mol Human Genet 10(5):445-456
19. Tremble PM, Lane TF, Sage EH, Werb Z (1993) SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol 121(6):1433-1444
20. Powell DW, Mifflin RC, Valentichet JD (1999) Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol 277(2 Pt 1):C183-C201
21. Chlenski A, Guerrero LJ, Yang Q, Tian Y et al. (2007) SPARC enhances tumor stroma formation and prevents fibroblast activation. Oncogene 26:4513-4522
22. Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H (1998) Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol 141(5):1277-1286
23. Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG, Karl IE (1997) Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med 25(8):1298-1307
24. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162(1):156-159
25. Neurath MF, Kelasall BL, Presky DH, Waegell W and Strober W (1996) Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 183(6):2605-2616